#oncology

Collection of oncology news, found 172 news.

NTHU’s Boron Neutron Capture Therapy Center begins treating overseas brain cancer patients

- On February 14th the melodious strains of the fourth movement of Mahler's Fifth Symphony were heard inside the ...

Takeda completes sale of select OTC and non-core assets to Acino

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its ...

Takeda agrees to divest select OTC and non-core assets in Latin America to Hypera Pharma for $825 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to ...

Aptorum Group announces significant progress of repurposed drug candidate, SACT-1 for neuroblastoma targeting IND submission in H2 2020

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Invicro LLC announces Dr. Matthew Silva as new Chief Executive Officer and Dr. Jack Hoppin is named President of Konica Minolta Precision Medicine

- Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief ...

Takeda continues strategic divestitures with sale of select OTC and non-core assets to STADA for $660 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

The Mary Kay Foundation donates $100,000 to Baylor Scott & White to support triple negative breast cancer research

- The Mary Kay FoundationSM, a decades-long leader in the mission to eliminate cancers affecting women, recently ...

Takeda agrees to divest select OTC and non-core assets to Acino for over $200 million USD

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an ...

Hansoh Pharma and Atomwise launch strategic AI drug discovery collaboration for multiple therapeutic areas

- Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and ...

Aptorum Group has initiated IND-enabling studies for its ALS-4 small molecule candidate for the treatment of infections caused by staphylococcus aureus including MRSA

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group announces the development of microbiome drug candidate targeting obesity and repurposed drug candidates targeting neuroblastoma

- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of ...

Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN

- Aptorum Group Limited (Nasdaq: APM) subsidiary Smart Pharmaceutical is excited to announce that the Smart Pharma ...

Takeda completes sale of Xiidra® to Novartis

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its sale ...

Takeda simplifies portfolio and accelerates deleveraging through two divestitures

- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into ...